3/19
10:34 am
ino
Rating for INO
Low
Report
Rating for INO
3/19
10:34 am
ino
Rating for INO
Low
Report
Rating for INO
3/19
08:04 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.